Photo from Petros Grivas/X
Jan 5, 2024, 11:46
Petros Grivas: This is a product of teamwork for many years
Petros Grivas, Associate Professor at University of Washington, shared on X/Twitter:
“This is a product of teamwork for many years: investigator-initiated trial of nivolumab +/- lirilumab as neoadjuvant treatment in cisplatin-ineligible patients with MIBC! Vadim Koshkin was a fellow when we started!”
Visit the article website.
Source: Petros Grivas/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 21, 2024, 06:49
Nov 20, 2024, 20:38
Nov 20, 2024, 20:27
Nov 20, 2024, 19:12
Nov 20, 2024, 19:12